The protein known as shieldin complex subunit 1 is a constituent of the shieldin complex, a multi-protein assembly that plays a crucial role in DNA repair, specifically in the pathway of non-homologous end joining (NHEJ). NHEJ is one of the primary mechanisms by which cells repair double-strand breaks (DSBs) in DNA, a type of damage that can result from radiation, oxidative stress, and various chemical exposures. DSBs are among the most deleterious forms of DNA damage, and their accurate repair is essential for maintaining genomic stability and preventing conditions such as cancer.Shieldin complex subunit 1 collaborates with other components in the shieldin complex to facilitate the repair process. The complex is believed to be involved in the sensing of broken DNA ends, as well as in the protection of DNA at break sites against resection. This protection is important because excessive resection can lead to loss of genetic information and can impact the repair process negatively.
The shieldin complex is also implicated in the regulation of the activity of the DNA repair protein 53BP1, a key player in the NHEJ pathway. By interacting with 53BP1, the shieldin complex helps to modulate the choice of DNA repair pathway-favoring NHEJ over homologous recombination (HR)-particularly in the G1 phase of the cell cycle when sister chromatids are not available as repair templates.Disruption or mutations in "shieldin complex subunit 1" can lead to deficiencies in DSB repair, resulting in increased sensitivity to DNA-damaging agents and a predisposition to genomic instability. This instability is a hallmark of many cancers, and as such, the function of "shieldin complex subunit 1" and its interactions within the DNA damage response are of significant interest in cancer biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
Olaparib is a PARP inhibitor, affecting DNA repair and particularly relevant in HR-deficient cells, potentially influencing SHLD1-related pathways. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Rucaparib, another PARP inhibitor, impacts DNA repair mechanisms, relevant in cells with compromised HR, like those involving SHLD1. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
Niraparib is a PARP inhibitor, used to target DNA repair pathways, particularly in cancer cells with HR deficiencies. | ||||||
Talazoparib | 1207456-01-6 | sc-507440 | 10 mg | $795.00 | ||
Talazoparib, a potent PARP inhibitor, affects DNA damage response and is particularly effective in HR-compromised cells. | ||||||
Veliparib | 912444-00-9 | sc-394457A sc-394457 sc-394457B | 5 mg 10 mg 50 mg | $178.00 $270.00 $712.00 | 3 | |
Veliparib is a PARP inhibitor that may indirectly affect SHLD1 function by modulating DNA repair pathways. | ||||||
Ceralasertib | 1352226-88-0 | sc-507439 | 10 mg | $573.00 | ||
AZD6738 inhibits ATR kinase, affecting the DNA damage response and cell cycle checkpoints, potentially relevant to SHLD1's role. | ||||||
2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(4-(4-methylpiperazin-1-yl)phenylamino)-1,2-dihydropyrazolo[3,4-d]pyrimidin-3-one | 955365-80-7 | sc-483196 | 5 mg | $340.00 | 1 | |
MK-1775 is a WEE1 kinase inhibitor, affecting cell cycle progression and DNA damage repair, potentially influencing SHLD1. | ||||||
PF 477736 | 952021-60-2 | sc-362781 sc-362781A | 5 mg 25 mg | $113.00 $423.00 | ||
PF-477736 inhibits CHK1, a kinase involved in DNA damage response and cell cycle regulation. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $350.00 | 10 | |
NU7441 is a specific inhibitor of DNA-PK, a key enzyme in NHEJ, a pathway where SHLD1 may play a role. | ||||||
KU 60019 | 925701-46-8 | sc-363284 sc-363284A | 10 mg 50 mg | $243.00 $1015.00 | 1 | |
KU-60019 inhibits ATM kinase, involved in the DNA damage response and potentially intersecting with SHLD1-related pathways. |